Xuefeng Li

733 citations
34 papers · 389 indexed · h-index 10
Topics
Metabolism, Diabetes, and Cancer (5 papers)Peripheral Artery Disease Management (4 papers)Diabetes Treatment and Management (4 papers)

In The Last Decade

Xuefeng Li

30 papers receiving 382 citations

Peers

Xuefeng Li
Comparison fields: 5 of 79
  • Surgery 138
  • Molecular Biology 113
  • Pathology and Forensic Medicine 64
  • Endocrinology, Diabetes and Metabolism 63
  • Epidemiology 50
Replace Yunzhi Chen with:
Yunzhi Chen China
Leticia González Chile
Qingsong Tao China
Xinwen Yu China
Chenyang Wang China
Marek Waluga Poland
Jiun-Liang Chen Taiwan
Jesús García‐Bañuelos Mexico
Jason Behary Australia
Xuefeng Li relative to Yunzhi Chen China Yunzhi Chen's profile →
Citations per field
00.5×5.6×
Yunzhi Chen · 1×
Citations per year

Countries citing papers authored by Xuefeng Li

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Li more than expected).

Fields of papers citing papers by Xuefeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Li. The network helps show where Xuefeng Li may publish in the future.

Co-authorship network of co-authors of Xuefeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Li. A scholar is included among the top collaborators of Xuefeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Li. Xuefeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 8
5 6
6 26
7 12
8 3
9 1
10 2
11 20
12 6
13 109
14 18
15 9
16
Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter.
6
17 35
18 42
19 3
20 7

About Xuefeng Li

Xuefeng Li is a scholar working on Gastroenterology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 34 papers that have together received 389 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (5 papers), Peripheral Artery Disease Management (4 papers) and Diabetes Treatment and Management (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (63 citations), Pathology and Forensic Medicine (64 citations) and Surgery (138 citations). Xuefeng Li has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Junwei Cai, Longying Zha, Zhenqi Liu, Wenhong Cao, Limei Mao, Xinwei Chu, Suxia Sun, Hong Deng, Fang Wang and Xiaoping Wu. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026